" /> Canakinumab - CISMeF





Preferred Label : Canakinumab;

NCIt definition : A recombinant monoclonal antibody targeting human interleukin-1 beta (IL-1b), with anti-inflammatory and immunomodulating activities. Canakinumab binds IL-1b and prevents the binding of IL-1b to the IL-1 receptor and inhibits IL-1b-mediated signaling. This may suppress inflammatory responses mediated by IL-1b. IL-1b, a proinflammatory cytokine, plays a key role in inflammation.;

UNII : 37CQ2C7X93;

CAS number : 914613-48-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 914613-48-2 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Ilaris;

Molecule name : ACZ885;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.